Alzheon To Present At Upcoming Investor Conferences
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric disorders, today announced that the company will present at these upcoming investor conferences: